US equities |
MU $833.59 ▼-5.78% NVDA $202.06 ▼-1.26% AAPL $338.32 ▼-1.83% MSFT $507.12 ▼-2.83% TSLA $403.82 ▲+1.00% AMD $466.84 ▼-7.52% AMZN $245.63 ▲+2.20% INTC $59.97 ▼-8.80%
FinancialContent

Pulmonx Corporation - Common Stock (NQ:LUNG)

2.580 -0.430 (-14.29%)
Delayed Quote Updated: 4:00 PM EST, Nov 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pulmonx Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
From Pulmonx Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Earnings Preview For Pulmonx ↗
 
Via Benzinga
News headline image
Navigating 6 Analyst Ratings For Pulmonx ↗
 
Via Benzinga
News headline image
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
From Pulmonx Corporation
Via Business Wire
News headline image
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Analyst Ratings For Pulmonx ↗
 
Via Benzinga
News headline image
Pulmonx to Present at the Stifel 2024 Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx Reports Third Quarter 2024 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx Reports Second Quarter 2024 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
From Pulmonx Corporation
Via GlobeNewswire
News headline image
5 Medical Info Systems Stocks To Buy For Stable Returns ↗
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024. 
Via Talk Markets
News headline image
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Pulmonx Corporation
Via GlobeNewswire
News headline image
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday! 
Via InvestorPlace
News headline image
LUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024 ↗
LUNG stock results show that Pulmonx beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Pulmonx Reports First Quarter 2024 Financial Results
Achieves 30% year-over-year worldwide revenue growth 
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Pulmonx Corporation
Via GlobeNewswire
News headline image
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
From Pulmonx Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >